| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.02 |